BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15893968)

  • 1. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C
    Dig Liver Dis; 2005 Jul; 37(7):468-74. PubMed ID: 15893968
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M
    Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
    Kanayama S
    Nihon Rinsho; 1999 Jan; 57(1):153-6. PubMed ID: 10036954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 6. [Continuation of acid suppression therapy after H. pylori eradication].
    Takahashi M; Kuwayama H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():531-5. PubMed ID: 11979841
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reflux esophagitis].
    Mitsunaga A; Matsumoto R; Hoshino Y; Nakamura S; Murata Y; Oi I; Hayashi N
    Nihon Rinsho; 2002 Aug; 60(8):1559-65. PubMed ID: 12187751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC
    Am J Manag Care; 2000 Aug; 6(8):934-5. PubMed ID: 11186505
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori and omeprazole therapy in GERD.
    Kuipers EJ; Schenk BE; Klinkenberg-Knol EC; Meuwissen SG
    Am J Gastroenterol; 1999 Nov; 94(11):3378-9. PubMed ID: 10566757
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intractable ulcer].
    Yoshida Y; Miyatani H; Tokuyama T; Hirakawa R
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():583-6. PubMed ID: 11979851
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Chassany O; Bergmann JF
    Rev Prat; 1998 Apr; 48(8):893-8. PubMed ID: 11767336
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of gastroesophageal reflux disease: to step or not to step.
    McGuigan JE
    Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
    [No Abstract]   [Full Text] [Related]  

  • 15. [GERD after H. pylori eradication therapy].
    Kinoshita Y; Adachi K; Ishihara S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():477-82. PubMed ID: 11979831
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of acid suppression in subjects with Helicobacter pylori infection].
    Fujisawa T; Adachi K; Kinoshita Y
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():387-90. PubMed ID: 16363565
    [No Abstract]   [Full Text] [Related]  

  • 17. Soothing the burn. Modern management of GERD.
    Covington C
    Adv Nurse Pract; 2001 Jul; 9(7):65-8, 70, 72 passim. PubMed ID: 12420457
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to use proton pump inhibitors and histamine H2 antagonists in the therapy of peptic ulcer].
    Yabana T; Kobayashi T; Sugiyama T
    Nihon Naika Gakkai Zasshi; 1995 Jun; 84(6):905-10. PubMed ID: 7658123
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recent topics in the medical treatment of reflux esophagitis].
    Hiraishi H; Shimada T; Terano A
    Nihon Geka Gakkai Zasshi; 1997 Nov; 98(11):942-6. PubMed ID: 9488979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.